.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
US Department of Justice
Dow
Deloitte
Merck
Citi
Healthtrust
Queensland Health
Chinese Patent Office
Fish and Richardson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Sign Up

« Back to Dashboard

Details for Patent: ➤ Sign Up

Title: 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect
Abstract:1-phenyl-3-dimethylaminopropane compounds corresponding to the formula I ##STR1## a method of preparing them, and the use of these substances as analgesic active ingredients in pharmaceutical compositions.
Inventor(s): Buschmann; Helmut (Aachen, DE), Strassburger; Wolfgang (Wuerselen, DE), Friderichs; Elmar (Stolberg, DE)
Assignee: Gruenthal GmbH (Aachen, DE)
Filing Date:Apr 20, 2001
Application Number:09/838,192
Claims:1. A method of preparing a 1-phenyl-3-dimethylaminopropane compound corresponding to formula ##STR41##

wherein

X represents OH, F, Cl, H or an OCOR.sup.6 group in which R.sup.6 is a C.sub.1-3 -alkyl group;

R.sup.1 is a C.sub.1-4 -alkyl group;

R.sup.2 represents H or a C.sub.1-4 -alkyl group, and R.sup.3 represents H or a straight chain C.sub.1-4 -alkyl group, or R.sup.2 and R.sup.3 together form a C.sub.4-7 cycloalkyl radical;

when R.sup.5 represents H, R.sup.4 represents:

(A) meta-O--Z, wherein Z is H, C.sub.1-3 -alkyl, PO(OC.sub.1-4 alkyl).sub.2, CO(OC.sub.1-5 -alkyl), CONH--C.sub.6 H.sub.4 --(C.sub.1-3 -alkyl) or CO--C.sub.6 H.sub.4 --R.sup.7, in which R.sup.7 is ortho-OCOC.sub.1-3 -alkyl or meta- or para-CH.sub.2 N(R.sup.8).sub.2, where R.sup.8 is C.sub.1-4 -alkyl or 4-morpholino, or

(B) meta-S--C.sub.1-3 -alkyl, meta-Cl, meta-F, meta-CR.sup.9 R.sup.10 R.sup.11, ortho-OH, ortho-O--C.sub.2-3 -alkyl, para-F or para-CR.sup.9 R.sup.10 R.sup.11, where R.sup.9, R.sup.10 and R.sup.11 independently represent H or F;

when R.sup.5 represents para-Cl, para-F, para-OH or para-O--C.sub.1-3 -alkyl, R.sup.4 represents meta-Cl, meta-F, meta-OH or meta-O--C.sub.1-3 -alkyl; or

R.sup.4 and R.sup.5 together represent 3,4-OCH.dbd.CH-- or 3,4-OCH.dbd.CHO--,

as diastereoisomers or enantiomers in the form of free bases;

said method comprising:

(1) reacting a compound of formula I in which X represents Cl with at least one substance selected from the group consisting of zinc borohydride, zinc cyanoborohydride and tin cyanoborohydride to form a final compound in which X represents H;

(2) reacting a compound of formula I in which X represents OH with dimethylaminosulfur trifluoride in a solvent to form a final compound in which X represents F;

(3) reacting a compound of formula I in which X represents OH with thionyl chloride to form a final product in which X represent Cl;

(4) reacting a compound of formula I in which X represents OH or with an acid chloride Cl--COOR.sup.6 to form a final compound in which X represents OCOR.sup.6 ; or

(5) reacting a .beta.-dimethylaminoketone of formula II ##STR42##

with an organometallic compound of formula III ##STR43##

in which Z represents MgCl, MgBr, MgI or Li to form a final compound in which X represent OH; and

optionally converting a free base into a salt with a physiologically acceptable acid.

2. A method according to claim 1, wherein

X represents OH, F, Cl or H;

R.sup.1 represents a C.sub.1-4 -alkyl group;

R.sup.2 represents H or CH.sub.3 ;

R.sup.3 represents H or CH.sub.3, and

R.sup.5 represents H, and R.sup.4 represents meta-OC.sub.1-3 -alkyl, meta-OH, meta-S--C.sub.1-3 -alkyl, meta-F, meta-Cl, meta-CH.sub.3, meta-CF.sub.2 H, meta-CF.sub.3 or para-CF.sub.3, or

R.sup.5 represents para-Cl or para-F, and R.sup.4 represents meta-Cl or meta-F, or

R.sup.4 and R.sup.5 together represent 3,4-OCH.dbd.CH--.

3. A method according to claim 1, wherein R.sup.2 and R.sup.3 have different meanings, and wherein said compound is a diastereoisomer having the configuration Ia ##STR44##

4. A method according to claim 1, in which X represents OH, said method comprising reacting a .beta.-dimethylaminoketone of formula II ##STR45##

with an organometallic compound of formula III ##STR46##

in which Z represents MgCl, MgBr, MgI or Li.

5. A method according to claim 1, in which X represents H, said method comprising reacting a compound of formula I in which X represents Cl with at least one substance selected from the group consisting of zinc borohydride, zinc cyanoborohydride and tin cyanoborohydride.

6. A method according to claim 1, in which X represents F, said method comprising reacting a compound of formula I in which X represents OH with dimethylaminosulfur trifluoride in a solvent.

7. A method according to claim 1, in which X represents Cl, said method comprising reacting a compound of formula I in which X represents OH with thionyl chloride.

8. A method according to claim 1, in which X represents an OCOR.sup.6 group in which R.sup.6 is C.sub.1-3 -alkyl group, said method comprising reacting a compound of formula I in which X represents OH with an acid chloride Cl--COOR.sup.6.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Merck
UBS
Federal Trade Commission
Baxter
Teva
Boehringer Ingelheim
US Department of Justice
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot